UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype

Journal of thrombosis and haemostasis, 2008-03, Vol.6 (3), p.486-493

2008

Volltextzugriff (PDF)

Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-11, Vol.17 (6), p.944-951

2011

Volltextzugriff (PDF)

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM‐1VWD study

Journal of thrombosis and haemostasis, 2009-08, Vol.7 (8), p.1304-1312

2009

Volltextzugriff (PDF)

Compound heterozygosity or heterozygosity with two mutations in cis on the same allele? A rebuttal to the letter to the Editors: Koessler et al. Von Willebrand disease caused by compound heterozygosity for p.R854Q and p.R760C: diagnostic and therapeutic implications. Haemophilia 2011; 17: e240-2

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.e832-e833

2011

Volltextzugriff (PDF)

Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia

Thrombosis and haemostasis, 1992, Vol.68 (1), p.95-96

1992

Volltextzugriff (PDF)

von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2

Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.868-870

2007

Volltextzugriff (PDF)

French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance

Thrombosis and haemostasis, 1998-11, Vol.80 (5), p.779-783

1998

Volltextzugriff (PDF)

First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene

Journal of thrombosis and haemostasis, 2004-12, Vol.2 (12), p.2271-2273

2004

Volltextzugriff (PDF)

International survey of patients with von Willebrand disease and angiodysplasia

Thrombosis and haemostasis, 1993-09, Vol.70 (3), p.546-546

1993

Volltextzugriff (PDF)

Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion

Journal of thrombosis and haemostasis, 2006-01, Vol.4 (1), p.148-157

2006

Volltextzugriff (PDF)

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A

Haematologica (Roma), 2018-01, Vol.103 (1), p.179-189

2018

Volltextzugriff (PDF)

A new automated method for von Willebrand factor antigen measurement using latex particles

Thrombosis and haemostasis, 1999-02, Vol.81 (2), p.320-321

1999

Volltextzugriff (PDF)

Gene Defects in 150 Unrelated French Cases with Type 2 von Willebrand Disease: from the Patient to the Gene

Thrombosis and haemostasis, 1997, Vol.78 (1), p.451-456

1997

Volltextzugriff (PDF)

Compound heterozygosity or heterozygosity with two mutations in cis on the same allele?

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.e832-e833

2011

Volltextzugriff (PDF)

New variant of von Willebrand disease with defective binding to factor VIII

Blood, 1989-10, Vol.74 (5), p.1591-1599

1989

Volltextzugriff (PDF)

von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system

Thrombosis and haemostasis, 2000-10, Vol.84 (4), p.727-728

2000

Volltextzugriff (PDF)

Somatic mosaicism and compound heterozygosity in female hemophilia B

Blood, 2000-08, Vol.96 (4), p.1585-1587

2000

Volltextzugriff (PDF)

A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (αIIbβ3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia–like phenotype

Blood, 2001-10, Vol.98 (8), p.2432-2441

2001

Volltextzugriff (PDF)

Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death

Haemophilia : the official journal of the World Federation of Hemophilia, 2005-09, Vol.11 (5), p.452-458

2005

Volltextzugriff (PDF)

Acquired von Willebrand syndrome: from pathophysiology to management

Thrombosis and haemostasis, 2000-08, Vol.84 (2), p.175-182

2000

Volltextzugriff (PDF)

Validation of the first commercial ELISA for type 2N von Willebrand’s disease diagnosis: A NEW ELISA FOR TYPE 2N VON WILLEBRAND’S DISEASE DIAGNOSIS

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-11, Vol.17 (6), p.944-951

2011

Volltextzugriff (PDF)

Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF

Thrombosis and haemostasis, 1999-11, Vol.82 (5), p.1382-1385

1999

Volltextzugriff (PDF)

Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

Best practice & research. Clinical haematology, 2001-06, Vol.14 (2), p.337-347

2001

Volltextzugriff (PDF)

Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate

Thrombosis and haemostasis, 1995-02, Vol.73 (2), p.215-218

1995

Volltextzugriff (PDF)

Scott syndrome: an inherited defect of the procoagulant activity of platelets

Platelets (Edinburgh), 1997, Vol.8 (2-3), p.117-124

1997

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(79)
Französisch
(23)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype

Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM‐1VWD study

Compound heterozygosity or heterozygosity with two mutations in cis on the same allele? A rebuttal to the letter to the Editors: Koessler et al. Von Willebrand disease caused by compound heterozygosity for p.R854Q and p.R760C: diagnostic and therapeutic implications. Haemophilia 2011; 17: e240-2

Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia

von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2

French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance

First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene

International survey of patients with von Willebrand disease and angiodysplasia

Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A

A new automated method for von Willebrand factor antigen measurement using latex particles

Gene Defects in 150 Unrelated French Cases with Type 2 von Willebrand Disease: from the Patient to the Gene

Compound heterozygosity or heterozygosity with two mutations in cis on the same allele?

New variant of von Willebrand disease with defective binding to factor VIII

von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system

Somatic mosaicism and compound heterozygosity in female hemophilia B

A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (αIIbβ3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia–like phenotype

Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death

Acquired von Willebrand syndrome: from pathophysiology to management

Validation of the first commercial ELISA for type 2N von Willebrand’s disease diagnosis: A NEW ELISA FOR TYPE 2N VON WILLEBRAND’S DISEASE DIAGNOSIS

Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF

Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate

Scott syndrome: an inherited defect of the procoagulant activity of platelets

Aktive Filter

Suchergebnisse filtern